Bio Answer Holdings, Inc. — FDA Facility Profile

FEI 3004870884

Bio Answer Holdings, Inc. is an FDA-inspected facility (FEI 3004870884) located in Hauppauge, NY, US. RegDataLab tracks 13 FDA inspections and 2 compliance actions at this facility.

Reviewing Bio Answer Holdings, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Bio Answer Holdings, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
May 5, 2025: Voluntary Action Indicated (VAI)
Inspections on record
13 (8 VAI, 5 NAI)
Last OAI inspection
None on record
Warning letters
2 listed by FDA for this FEI, latest May 5, 2021
Recalls as the recalling firm
2, latest May 13, 2021

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 13 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
May 5, 2025Voluntary Action Indicated (VAI)Standard reference materials; criteria for selecting (21 CFR 111.315(d))
Quality control - batch, product specifications (21 CFR 111.123(b)(2))
Specifications - components (21 CFR 111.70(b))
Specifications - finished dietary supplement (21 CFR 111.70(e))
and 1 more
Sep 19, 2022Voluntary Action Indicated (VAI)Criteria for establishing specifications; reviewed, approved (21 CFR 111.315(a))
Quality control - verification requirements, exempted (21 CFR 111.105(e))
Quality control - batch, product specifications (21 CFR 111.123(b)(2))
Jul 27, 2018Voluntary Action Indicated (VAI)Written procedure quality control operations material review (21 CFR 111.103)
Sep 9, 2016Voluntary Action Indicated (VAI)Personnel - education, training, experience (21 CFR 111.12(c))
Physical plant - repair (21 CFR 111.15(b)(2))
Manufacturing operations - prevent contamination (21 CFR 111.365)
Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))
and 2 more
Aug 15, 2016No Action Indicated (NAI)Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))
Packaging description, representative label (21 CFR 111.210(g))
Product complaint - quality control investigate (21 CFR 111.560(a)(2))
Product complaint -investigate, findings, follow-up (21 CFR 111.560(c))
and 3 more
Apr 8, 2015No Action Indicated (NAI)No citations listed
Apr 1, 2013Voluntary Action Indicated (VAI)No citations listed
Aug 10, 2012Voluntary Action Indicated (VAI)Master manufacturing record - each batch (21 CFR 111.205(a))
Jul 30, 2012No Action Indicated (NAI)No citations listed
Sep 6, 2011No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
May 13, 2021Class IIF-1000-2022NATURE's ANSWER Coral Calcium; Antioxidant Benefits*; 1000mg Coral Calcium per serving…
Product contained cesium chloride, a New Dietary Ingredient
Sep 9, 2016Class IIF-0906-2017Liquid VITAMIN D-3 Drops distributed under the following private labels and sizes: a)…
The lots exceed the label claim for Vitamin D3 of 2000 IU per drop.

Facility details

Company
Bio Answer Holdings, Inc.
Location
Hauppauge, NY (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.